Please login to the form below
trial data
This page shows the latest trial data news and features for those working in and with pharma, biotech and healthcare.
Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
New data from KEYNOTE-590 trial was presented at ESMO 2020 virtual congress. ... Merck plans to share the data from KEYNOTE-590 with global regulatory authorities over the coming months.
Latest news
-
Positive COPD data for Synairgen's SNG001 supports COVID-19 programme
UK biotech says data is encouraging for separate trial programme in COVID-19. ... Interim analysis from the phase 2 trial in COPD patients with confirmed respiratory viral infection found that treatment with SNG001 improved lung antiviral responses
-
Novacyt launches diagnostic test to differentiate between COVID-19 and flu
RSV). According to the company, clinical trial data of the test demonstrated 100% specificity and between 96% and 100% sensitivity across the panel.
-
Moderna’s COVID-19 vaccine shows promise in older adults
Early trial data from small group is encouraging. Moderna’s mRNA-based COVID-19 vaccine has shown promise in an early trial involving a small group of elderly participants, the company
-
Novartis' asciminib tops Pfizer's Bosulif in chronic myeloid leukaemia trial
Drug improved major molecular response compared to existing med. Novartis experimental drug asciminib beat Pfizer’s Bosulif in a phase 3 trial in previously-treated chronic myeloid leukaemia (CML) patients, offering ... According to Novartis, data from
-
Novavax begins phase 2 portion of COVID-19 vaccine trial
We expect this phase 2 portion of the trial to expand on the encouraging phase 1 safety and immunogenicity data for NVX-CoV2373, and we will now look for robust immune ... We know that the world is closely watching all of these trials, and we anticipate
More from news
Approximately 45 fully matching, plus 711 partially matching documents found.
Latest Intelligence
-
Exploiting the value of data in pharma
How using data in an agile way can dramatically accelerate innovation and clinical trials. ... relevant data, allows companies to consolidate widespread trial or clinical data effectively and rapidly to create common data sets or platforms that they can
-
The impact of COVID-19 on clinical trials
COVID-19 will have regulatory implications in terms of required documentation, protocol changes and deviations, data collection and the interpretation of trial results. ... They could succumb to the disease, in which case they will need to be removed
-
Addressing the payer-regulator evidence gap in early-stage cancer
Reimbursement bodies that need to evaluate effectiveness and value frequently request additional data to make their decisions. ... to be made available, unless data using other, non-OS, endpoints can be considered.
-
COVID-19: the race to find a vaccine
The importance of the drug to a world paralysed by COVID-19 is such that a leaked report of an encouraging, incomplete snapshot of data from a remdesivir trial sent the ... A clinical trial of Regeneron’s drug is scheduled to start in June.
-
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Anecdotal data also suggests NF1 has a detrimental impact on childhood development, but clinical studies are needed to tease out its neurological traits. ... The SPRINT trial data – showing a 66% response in patients with NF1-PN – only confirmed that
More from intelligence
Approximately 0 fully matching, plus 58 partially matching documents found.
Latest appointments
-
Clinerion appoints new regional head
Bariş Erdoğan takes up new role at the clinical trial data firm. ... Swiss-based clinical trial data firm Clinerion has appointed Bariş Erdoğan as its new regional head in a role that focuses on the expansion of its activities in Eastern Europe, the
-
Sanofi CEO Viehbacher to head EFPIA
One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.
-
Eric Green named NIH's data science lead
Dr Eric Green, current director of the National Human Genome Research Institue (NHGRI), is to serve as the first associate director for data science at the US National Institutes for Health ... This project offers a data repository with demographics,
-
Almac appoints Charlie Morris as VP new products and services in clinical technologies division
According to the company, which provides services to the pharma industry, he will oversee the development of its IXRS technology to manage patients, supplies, and clinical trial data.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Outsourcing in Clinical Trials 2020 Virtual Conference
And with this in mind, we need effective tools that enhance the collaboration of sharing data. ... Blockchain is already being used to decentralise data elsewhere, and within the clinical trial space, it has the potential to build trust by securely
-
Why are new medicinal products denied reimbursement in France?
4. Study population (e.g. uncertainty regarding the generalisability of the data to the wider patient population due to inclusion criteria employed in the trial). ... Furthermore, once pivotal trial data becomes available, the proposed positioning of a
-
EPG Health
With advanced technology, an established HCP audience and digital expertise (in strategy, user experience, content crafting and data), EPG Health follows an 8 step roadmap for delivering each bespoke HCP engagement ... Group Director Scientific
-
How to measure and maximise your patient recruitment spend ROI
Using emotion to connect with people through your clinical trial advertising is important. ... Customised, adaptable digital marketing campaigns, better sharing and transparency of data, health seeker-centric trial design, and remote patient monitoring
-
Understanding the evolving CAR-T market
The clinical data readout for the AUTO5 trial showed that it “may not be differentiated from more advanced competitor programmes.” The trial has been halted and Autolus is instead focusing on
More from PMHub
Approximately 1 fully matching, plus 23 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
